Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A study to look at how safe divarasib is when given on its own or in combination with other anti-cancer therapies, and how well these medici… Recruiting

2023-507171-22-00 Untreated Advanced or Metastatic Non-Small Cell Lung Ca 9 2023-06-21
A phase 1/2 open-label, multicenter study to assess the safety, pharmacokinetics and anti-tumor activity of GTAEXS617 in patients with advan… Recruiting

2023-508227-13-00 Advanced solid tumors 7 2023-06-19
Randomized phase 2 study of Valproic acid combinEd with Simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic P… Recruiting

2024-518710-11-00 Metastatic pancreatic ductal adenocarcinoma (mPDAC) 4 2023-06-12
Early phase study to evaluate the safety and efficacy of SMART101 to improve transplantation in blood cancers Recruiting

2024-517953-28-00 Treatment in haematopoietic stem cell transplantation 7 2023-06-07
Benefit of transplantation after Complete Response In Patients with T-cell lymphoma Recruiting

2022-501710-62-02 Peripheral T-cell lymphoma (PTCL) 6 2023-06-07
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in R/R PCNSL Recruiting

2024-513312-95-00 Part B+C. Primary central nervous system lymphoma (PCNS 7 2023-05-30
A Study of Debio 0123 in Combination with Temozolomide in Adult Participants with Recurrent or Progressive Glioblastoma and of Debio 0123 in… Recruiting

2022-502156-31-00 Glioblastoma 9 2023-05-26
A Rollover Study for Patients Previously Enrolled in a Genentech and/or F.Hoffman-La Roche Sponsored Study Recruiting

2023-504263-16-00 This is an extension study designed to provide continue 5 2023-05-25
Window-of-opportunity umbrella platform trial of short-course pre-operative targeted treatments in patients with molecularly selected and re… Recruiting

2022-501308-90-00 Molecularly selected and resectable primary colorectal 4 2023-05-24
This study has 2 phases: a Phase 1b evaluation of elacestrant in combination with abemaciclib followed by a Phase 2 evaluation of elacestran… Recruiting

2024-512878-98-00 Brain Metastasis from Estrogen Receptor Positive, HER-2 9 2023-05-16
Venetoclax in combination with Ibrutinib and Rituximab or conventional chemotherapy (Bendamustine) and Ibrutinib and Rituximab in patients w… Recruiting

2022-501808-96-00 Mantle Cell Lymphoma 4 2023-05-15
First-in-human study of OT-A201 in patients with selected hematological malignancies and solid tumors Recruiting

2024-511936-28-00 Relapsed/refractory hematological malignancies or adva 1 2023-05-12
Platform study of JDQ443 in combinations in patients with advanced solid tumors harboring the KRAS G12C mutation Recruiting

2023-506716-41-00 Adult patients with advanced (metastatic or unresectabl 9 2023-05-08
Immune-Related Rheumatological and neurological Adverse Events study. Recruiting

2024-516631-27-00 Cancer (all types) 4 2023-05-05
EDEN : Etude de désescalade thérapeutique et d'évaluation du marqueur miRNA M371 pour les séminomes de stade IIa/IIb < 3 cm Recruiting

2024-514636-25-00 Stage IIa/IIb < 3 cm seminoma 4 2023-05-04
68Ga-FAPI-46 PET-CT for molecular assessment of fibroblast activation and risk assessment in solid tumors (FAPI Basket) Recruiting

2024-511659-17-00 Solid tumors 4 2023-05-01
The ACTION Study: ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy Recruiting

2022-502051-56-00 H3 K27M-mutant diffuse glioma 5 2023-04-28
A Randomized, Open-label, Phase 3 Study of Acalabrutinib in Combination with Rituximab and Reduced Dose CHOP (R-miniCHOP) in Older Adults wi… Recruiting

2022-501187-18-00 a. Diffuse large B-cell lymphoma (DLBCL) not otherwise 5 2023-04-24
Prospective randomised study of the impact of preoperative administration of mitomycin-C by electromotive drug administration (EMDA) in pat… Recruiting

2024-510867-42-00 non-muscle invasive bladder tumors 6 2023-04-24
Master protocol of novel combinations in participants with locally advanced unresectable or metastatic gastric or gastroesophageal junction … Recruiting

2024-510977-27-00 Locally Advanced Unresectable or Metastatic Gastric or 4 2023-04-14
A prospective program aiming at improving outcome for young adults with poor-prognosis non seminomatous germ-cell tumors (VAPOR (GETUG T06)) Recruiting

2023-505040-19-00 Non-seminomatous germ-cell tumors (including testis, re 4 2023-04-11
A first-in-human clinical study of PBP1510 in patients with pancreatic cancer. Recruiting

2024-514379-16-00 Advanced and/or metastatic pancreatic adenocarcinoma 7 2023-04-01
Measuring Oncological Value of Exercise and Statin (MOVES) Recruiting

2024-515109-24-00 Metastatic breast, ovarian, prostate and kidney cancer 5 2023-03-31
MIRROR; Multispectral and bimodal fluorescent guided surgery (FGS) of high-grade glioma for refining margin assessment: A phase 1 dose findi… Recruiting

2024-513392-40-01 Glioblastoma 1 2023-03-31